Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

SMC approves Opdivo combo as first-line skin cancer treatment

Also backs Gilead’s Epclusa, Baxalta’s Oncaspar, AZ’s Lynparza and Amicus’ Galafold

- PMLiVE

Mylan facing US anticompetitive practice probe

Senate judiciary committee calls for fair competition review over EpiPen sales

- PMLiVE

Changing behaviour: putting theory into practice

In the November issue of PME, Madeleine Tye (senior account manager at Lucid Group) discusses Lucid’s approach to medical education. Lucid employs the outcomes of research into behavioural science in...

Lucid Group Communications Limited

Tajinder’s #LucidLife

Medical writers are like gold dust, so when we find talented writers with great experience,we offer a tailor-made package.Are you a world-class medical writer?Do you like the look of Tajinder’s...

Lucid Group Communications Limited

Fiona’s #LucidLife

Meet Fiona, a medical writer.She told us what she wanted, and we did the rest.We believe that medical writers are like gold dust; so when we find talent, we do...

Lucid Group Communications Limited

- PMLiVE

Claire Whitmarsh moves to Makara Health

She joins the leadership team as a director

Dispensing with the past

The pharma boards of the future

translational pharmacology medicine dose

Nearly half of all clinical trials not published

And industry shown to have a mixed record to date on study publication

- PMLiVE

Nestlé Health Science invests $145m in food allergy biotech

Aimmune Therapeutics' lead product is a phase III peanut allergy treatment

- PMLiVE

Why culture is too often the missing link in patient-centricity

Looking at the role culture plays in shaping attitudes and behaviour in healthcare

- PMLiVE

Ogilvy CommonHealth Worldwide promotes Scott Watson

He becomes global chief creative officer

- PMLiVE

MHRA launches medicines side effects awareness drive

Creates social media campaign as part of EU-wide initiative

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links